[ESPR] YoY Quarter Result on 30-Jun-2002 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
29-Jun-2002
Financial Year
2002
Quarter
30-Jun-2002 [#Q2]
Profit Trend
QoQ- -7.13%
YoY- -23.70%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/14 30/06/13 30/06/12 30/06/03 30/06/02 30/06/01 30/06/00 CAGR
Revenue 0 0 0 0 0 1 1 -
PBT -9,238 -6,921 -3,166 -8,435 -7,824 -6,325 -7,371 1.62%
Tax 18 112 304 922 888 -454 -308 -
NP -9,238 -6,921 -3,166 -8,435 -7,824 -6,325 -6,514 2.52%
Tax Rate - - - - - - - -
Total Cost 9,238 6,921 3,166 8,435 7,824 6,326 6,515 2.52%
Ratio Analysis
30/06/14 30/06/13 30/06/12 30/06/03 30/06/02 30/06/01 30/06/00 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -632,500.00 -651,400.00 -
Per Share
30/06/14 30/06/13 30/06/12 30/06/03 30/06/02 30/06/01 30/06/00 CAGR
EPS -0.60 -0.47 -0.33 -2.00 -1.87 -1.70 -20.60 -22.30%
EPS Diluted -0.60 -0.47 -0.33 -2.00 -1.87 -1.70 -20.60 -22.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.